Strides Arcolab receives USFDA's nod for Bangalore facility
USFDA, which inspected the facility in August 2014, has found Strides Arcolab's oral dosage facility acceptable
Strides Arcolab Ltd has announced that the company's oral dosage facility at KRS Gardens in Bangalore has been found acceptable by the US Food and Drug Administration (USFDA). The inspection was carried out in August 2014.
This facility in Bangalore manufactures oral dosage forms such as tablets, capsules (both hard gelatine and soft gelatine) and sachets. The manufacturing plant supports important current and future submissions for the US Market.
This facility in Bangalore manufactures oral dosage forms such as tablets, capsules (both hard gelatine and soft gelatine) and sachets. The manufacturing plant supports important current and future submissions for the US Market.